Challenges to Biosecurity From Advances in the Life Sciences
By Sergio Bonin,
UN Chronicle
| 07. 18. 2013
“Ring farewell to the century of physics, the one in which we split the atom and turned silicon into computing power. It's time to ring in the century of biotechnology.”1
This article summarizes the results of a qualitative risk assessment project on the biosecurity implications of developments in synthetic biology and nanobiotechnology carried out by the United Nations Interregional Crime and Justice Research Institute (UNICRI).2
Since the anthrax letter scare in the aftermath of 11 September 2001, attention in security policy discussions has shifted away from biological weapons and bioterrorism. It became increasingly clear that the acquisition of the necessary expertise and resources, as well as the successful execution of a biological attack, are far more complex than previously thought. Future advances in the field of biotechnology, however, might have the potential to change that. Even though the possible features and true potential of the coming biological revolution heralded by many observers is still a matter of controversy, it seems prudent to assess the security policy challenges of progress in biotechnology at an early stage, while allowing for the unhindered...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...